Glucocorticoids have been used to treat disorders such as sudden sensorineural hearing loss, autoimmune hearing loss, Meniere's disease, and hearing loss secondary to trauma, viral insult, and idiopathic causes. When used to treat disorders of the inner ear, steroids have traditionally been administered systemically. However, it has been postulated that the steroid levels achieved in the inner ear with systemic administration are not consistent because of the presence of the blood-labyrinth barrier. I This can lead to potentially suboptimal therapeutic concentrations and subsequent treatment failure.
Another concern with the systemic administration of steroids is the side effects associated with this route. Possible complications include fluid and electrolyte imbalance, muscle weakness and a loss of muscle mass, tendon rupture, osteoporosis, vertebral fractures, aseptic necrosis of the humeral and femoral heads, peptic ulcer, impaired wound healing, a cushingoid state, adrenocortical insufficiency, cataracts, and decreased carbohydrate tolerance.
In view of these concerns with systemic administration, other delivery routes have been investigated. Among the alternatives are intratympanic injection and topical administration into the middle ear cavity via a tympanostomy tube. But these routes have their own possible complications, including delayed healing of the tympanic membrane, vertigo, hearing loss, and morphologic changes in the round window mernbrane.i? In this article, the author reviews the advantages and disadvantages of topical steroid use in the middle and inner ear.
Literature search
The author searched the MEDLINE database for evidence-based articles that would help answer the clinical question, Are there potential risks associated with the use of steroids administered directly to the middle and inner ear spaces? The search terms used were "glucocorticoids and inner ear toxicity," "glucocorticoids and middle ear toxicity," "ototoxicity and ototopical steroids," "intratympanic steroids-middle ear toxicity," and "intratympanic steroids-inner ear toxicity."
The articles that were retrieved were reviewed in detail 24· Volume 86 • Suppl 1 to ascertain whether they answered the question. Most of those that did were reports of animal studies, although a few small series in humans were applicable, as well.
Extrapolating animal data to humans
Can data obtained from animal studies be extrapolated to humans? For practical reasons, the bulk of information available on the potential toxicity of steroid administration to the middle and inner ears via transtympanic administration has been derived from animal studies; sampling of inner ear fluids in humans poses a risk of permanent hearing loss. There are several anatomic differences between animal models and human models. For example, guinea pigs have a patent cochlear aqueduct, and this can lead to CSF contamination during perilymph sampling. Also, the human round window membrane is thicker than that of lower-order animals (70 urn for humans vs. 10 to 14 urn for rodents), and this difference may affect drug transport into the middle ear. Finally, because the human inner ear is considerably larger than that of animals used in most studies, it is difficult to make generalizations about drug concentrations within inner ear fluids." Roland et al identified several anatomic as well as nonanatomic differences between animals and humans and described some of the ramifications of these differences.'
For example, the human round window membrane is recessed in a triangular fossa and therefore is less accessible than the round window membrane in animals. As a result, substances placed in the middle ear of humans may remain in contact with the round window for a shorter period of time, thus potentially lessening their effect at this site . In an investigation of inner ear perfusion, Silverstein et al reported that nearly 30 % of the human ears in their study had obstructing mucosal folds that obscured the round window membrane."
Differences between humans and animals in eustachian tube function may exist as well, although much investigation in this area remains to be done . Again , if the anatomy of the human eustachian tube promotes the rapid movement of substances from the middle ear, potential contact time with the round window membrane would be reduced.
With regard to the nonanatomic differences, histologic changes in the round window have been seen in animals with otitis media. Specifically, these changes include increased vascularity, infiltration of immunoreactive cells and , eventually, thickening of the membrane, which may result in decreased permeability of the membrane over time.
Pending the accumulation of more data, we can only conclude for now that the extent to which animal data can be extrapolated to represent a human model is unknown.
Physiology: How steroids exert their effect
Corticosteroids exert their effect by strongly suppressing the immune system-mediated inflammatory response.This suppression occurs as a result of the interaction between the drug and the intracellular glucocorticoid receptors, which have been shown to exist in both cochlear and vestibular tissues of humans and rats . With respect to the location of steroid receptors, Rarey and Curtis found that the highest concentrations of receptors were in the cochlear labyrinth, specifically the spiral ligament, followed by the organ of Corti; the lowest concentration was in the stria vascularis.? In the vestibular labyrinth, the highest concentrations of receptors were in the crista ampullaris and utricular macula , and the lowest levels were in the macula of the saccule.
Before a glucocorticoid (or any other substance) can reach the inner ear and interact with the receptors there, it must pass through the round window. The transport of substances through this membrane is affected by its thickness, by the size and charge of various particles, by the presence of inflammation or injury to the membrane, and by the presence of facilitating agents.
Once the glucocorticoid enters the inner ear, we do not know much about how it travels in the inner ear fluid, the amount of time it spends in the inner ear, and its eventual anatomic distribution. Nor do we know if there are any differences between the various glucocorticoids with respect to distribution, concentration, and efficacy in the middle ear.
Pharmacokinetics in the middle and inner ear
The pharmacokinetic properties of the glucocorticoids must be taken into consideration because they can have an impact on the safety, efficacy, and feasibility of steroid delivery to the inner ear.
In 1999, Parnes et al established cochlear fluid pharmacokinetic profiles for hydrocortisone, methylprednisolone, and dexamethasone in the guinea pig following oral, intravenous, and intratympanic administration.10All three of these steroids successfully penetrated the blood-labyrinthine barrier and round window membrane and entered the inner ear fluid.The authors compared the concentrations of these drugs administered via these routes with simultaneous pharmacokinetic profiles of drug in blood and CSF.
They found that administration via the intratympanic route resulted in significantly greater inner ear levels of all three drugs at every sampling time when compared with administration via the systemic route. Perilymph concentrations of all three steroids peaked within the first hour, then rapidly declined. Similarly, peak endolymph levels were reached in 1 to 2 hours and they, too, rapidly declined. Of the three steroids, methylprednisolone had the highest concentrations Essentially, clearance can be defined as the removal of a substance from the cochlear fluid. When a drug is applied to the round window, the interplay between diffusion and clearance determines its distribution in the mner ear.
in both perilymph and endolymph, and levels remained measurable for the longest period of time.
In the same report, Parnes et al then described how they used these pharmacokinetic data in a clinical study of 37 patients with sensorineural hearing loss secondary to various inner ear disorders. 10 Of this group, 20 patients were treated with intratympanic dexamethasone and 17 with intratympanic methylprednisolone. The best overall responses were seen in 2 patients with Cogan's syndrome and I patient with clinical autoimmune inner ear disease. No case of treatment-induced hearing loss was seen, as auditory thresholds remained stable even in patients who did not respond to therapy. Some patients reported temporary vertigo at the time of injection, but no persistent dysfunction was seen. No permanent tympanic membrane perforations were found.
In 2000, Chandrasekhar et al reported the findings of a guinea pig study in which they compared perilymph concentrations of dexamethasone following systemic and intratympanic administration. I I Within 1 hour of administration, levels of the intratympanically delivered dexamethasone were significantly higher than levels of the intravenously administered drug. The difference was believed to be attributable in part to the low molecular weight and the high lipid solubility of dexamethasone, which would enhance its transport across the round window membrane. Intratympanic delivery did not result in any significant systemic absorption. Potential ototoxicity was not investigated in this study.
One hearin g loss who we re treated with intraty mpanic dexameth asone.'? Th ese findin gs corre lated with the findings of his group's earlier study " of guinea pigs-that is, perilymph conce ntrations of steroi d were sig nifica ntly higher with intratym panic administration than with intravenous de livery. No case of oti tis media, persistent tympanic perforation, or other complicat ion of intratym panic injection was seen .
In an attempt to further define the inne r ear pharmacoki netics of intratympanically inj ected dexamethaso ne, Hargun ani et al explored the conversio n of the prodru g dexamethasone 2 I-ph osph ate to its active form in the inner ea r.13Detection of either the prodrug or its active form revealed that dexam eth asone was present in the inner ear at 15 minutes and co mpletely gone after 24 hour s. Th e active form was detected as ea rly as the pro drug, suggesting that the convers ion occurred rapidly. Th is study provided co nfirmation that dexamethasone given by intra tympanic injection delivers act ive drug to the inner ear structures, bu t it also showed that the thera peutic window is probably ope n for less than 24 hour s after adminis tratio n.
Th rough a series of simulated application sce narios, Plontk e and Salt dem on strated that contro lling middle ear dru g clearance is ofcritical importance when administering the dru gs to the inner ea r.14 Th eir simulatio ns revealed that the longer a drug is applied to the round window mem brane, the higher the drug level is within the inner ear. Also, drug levels in the inner ear are sig nificantly higher when the rate of middle ear clearance is low.
Essentially, clearance can be defined as the removal of a substance from the coc hlear fluid. When a drug is applied to the round wi ndow, the interplay between diffusion and clearance determines its distribution in the inner ear. Sub stances that are qui ckl y cleared fro m the coc hlear fluid will rapidly reach a steady state in which diffusion and clearance are equal. As a res ult, a drug will never reac h the apical portion of the coc hlea in appreciable amounts . Substances with faster diffusion rates wi ll travel farther along the cochlea."
In summary, the highest intracochlear drug leve ls will be obtained with continuous delivery, and the lowest with a brief application.
Studies of potential complications
Result s of the treatm ent of sudden sensorineura l hearing loss with intraty mpanic glucocorticoids have been enco uraging. Likewise, the success of the ototopical steroid trea tment of tympanostomy tube otorrhea has been well described-and we ll received by the medical community. Even so, the concern for potential side effects associated with these therapies has been raised.
In a study in which 2% hydrocortisone was instilled through a tymp anic memb rane perforation into the round window niche of rat s for 5 consecuti ve days, Spand ow et 26' Volume 86 • Suppl 1 al de monstrated that auditory brainstem respo nses were permanently impaired in the freq uency region beyond 8 kl-lz.' Morph ologic investigati on detected no dam age to the inner ear. Th e tympanic membrane perforations throu gh which the stero id was instilled remained unhealed duri ng the first 3 weeks. At 2 months, 4 of 7 animals had persistent perforations.
To look at the effec ts of antibiotics and steroids on the middle ear mucosa, Park and Yeo inocula ted the rig ht ears of 27 rats with Streptococcus pneutnoniae; the left ears served as controls.' Th e animals were divi ded into three gro ups: 9 rats received intramuscular penicilli n G, 9 rats rece ived a comb ination ofpenicillin G and dexamethasone, and the remaining 9 rats were not treated . Th ree animals in eac h gro up were sacrificed on day 4 after challenge, 3 more were sacrificed on day 7, and the re mai ning 3 in eac h gro up on day 14 . Examination of their tympanic membranes and midd le ear mucosa demonstrated that the antibiotic/s teroid combination was more effective than the antibiotic alone in red ucing or preventing the persiste nce of mucosal changes . In fac t, the inflammatory responses in the middl e ear mucosa in the antibiotic-trea ted group were similar (although not as seve re) to the responses in the infected controls. By day 14, all of the tymp anic memb rane perforations in the infected co ntro l gro up had healed. In the antibiotic-treated gro up, the tymp anocentesis site was not found in any anima l on day 7. Healin g of the tympanocentesis site was slowest in the antibiotic/steroid gro up, but no animal exhib ited any persistent tympan ic mem brane perforation by day 14 .
Th e aforementioned study by Spandow et al revealed that hearin g loss occ urred in rats treated with hydr ocortisone appl ied to the middle ear.' On the other hand , Takeuchi and Anni ko found that dexameth asone reduce d the severity of hear ing loss ca used by Pseudomonas aeruginosa exo toxi n A. I !> Nordang et al cond ucted a controlled experime nt to determine whether different glucoco rticoids have the same effect on the round wi ndow mem brane.' Th ey insti lled eit her hydrocortisone or dexamethasone into the middle ears of 20 rats . Lig ht microscopy and transmission electron microscopy revealed an accumulation of inflam matory cells close to the round window memb ranes of those rats that had been expose d to hydrocorti sone but not in the round wind ow membra nes of rats that had been ex posed to dexamethasone. Furthermore, the hydrocortisone-exposed memb ranes were thicker than the dexamethasone-exposed and co ntrol membranes. Th e effect of hydrocortiso ne on the round window membran e ep ithelium seen by Nordang et aP corresponded with the findings of Spandow et al.'
Another potential complication assoc iate d with intratympanic steroi d injec tio n is the worsening of res idual hearing. Thus far, studies have been done on sensorineura l hearin g loss secondar y to Meniere's disease (in which spo ntaneo us fluctuation s in hearing are see n, makin g eva luatio n of changes in hearing extremely difficult ), sudde n se nso rineural hearing loss, and autoimmune inner ear disease. Hearing loss assoc iated wit h the latter two conditio ns is also difficult to eva luate because oft he natur al progression of the disease. In the series by Parnes et ai, It appears that steroids in the inner ear achieve peak concentration rapidly «1 hI') and are eliminated quickly «24 hr). no patient exhibited worsen ing of hear ing, and auditory threshold s remained stable in all unsuccessful treat ment cases. 10S imilarly, in the study of humans by Chand rasekhar, no patient experience d a rapid reductio n in heari ng afte r treatment (although audiometric data were not provided in this rep ort). 12 Clearly, the issue ofa further reduction in hea ring thresholds secondary to intratym panic steroi d use has not been definit ely settled by the studies done thus far. Th erefore, we should give considera tion to seve ral other fac tors as potent ial etio logies for hearing loss.Th ese possi ble fac tors include the natural progression of the disease, the ac tio n of carrier mo lecules in the steroi d prep aration, the presence of co nco mitant infection (bac terial or viral), the effect of traum a to the round window res ulting in a fistula, and the possible side effects of an anes thetic age nt.
Conclusion
In summa ry, it appears that steroids in the inner ear achieve peak co nce ntration rapidly « 1 hr) and are elimi nate d quickly «24 hr). Thus, when these age nts are administe red for a sho rt time, high intracochlear drug levels will not be achieved. It would appea r, then , that a short-ter m course of stero id would be an approp riate ototopical regim en for the treat ment of tymp anostom y tube otorr hea .
Finally, although some studies have shown that hydrocortisone may be assoc iated with changes in round window membrane morpho logy, this does not see m to be the case with dexamethaso ne. As for the potenti al for tympanic mem brane per fora tions associated with the use of stero ids, it appears that myringotomy healing is tran siently impaired with the use of dexamethasone.
